{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:15:48Z","timestamp":1786994148349,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.metabol.2004.04.010","type":"journal-article","created":{"date-parts":[[2004,8,27]],"date-time":"2004-08-27T14:24:01Z","timestamp":1093616641000},"page":"1227-1232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Effect of pramlintide on symptom, catecholamine, and glucagon responses to hypoglycemia in healthy subjects"],"prefix":"10.1016","volume":"53","author":[{"given":"Tim","family":"Heise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Weyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Strobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orville","family":"Kolterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Maggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2004.04.010_BIB1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/bst0230325","article-title":"Amylin regulation of carbohydrate metabolism","volume":"23","author":"Young","year":"1995","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.metabol.2004.04.010_BIB2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF00401833","article-title":"Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin","volume":"38","author":"Young","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2004.04.010_BIB3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-0495(96)90192-4","article-title":"Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7\u201336)NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake","volume":"45","author":"Young","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2004.04.010_BIB4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0026-0495(97)90170-0","article-title":"Dose-response for glucagonostatic effect of amylin in rats","volume":"46","author":"Gedulin","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2004.04.010_BIB5","first-page":"1083","article-title":"Acute effects of the human amylin analog AC137 on basal and insulin-stimulated euglycemic and hypoglycemic fuel metabolism in patients with insulin- dependent diabetes mellitus","volume":"81","author":"Nyholm","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2004.04.010_BIB6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2337\/diacare.18.8.1179","article-title":"Reduction of postrandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue","volume":"18","author":"Kolterman","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2004.04.010_BIB7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2337\/diab.41.3.255","article-title":"Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious cycle","volume":"41","author":"Cryer","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2004.04.010_BIB8","first-page":"E214","article-title":"Glucose clamp technique","volume":"237","author":"DeFronzo","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2004.04.010_BIB9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2337\/diacare.14.11.949","article-title":"Symptoms of acute insulin-induced hypoglycemia in humans with and without IDDM. Factor-analysis approach","volume":"14","author":"Hepburn","year":"1991","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2004.04.010_BIB10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/BF00401150","article-title":"Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis","volume":"36","author":"Deary","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2004.04.010_BIB11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/BF00400683","article-title":"Effect of 14 days\u2019 subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM","volume":"39","author":"Kolterman","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2004.04.010_BIB12","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/meta.2002.32022","article-title":"The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes","volume":"51","author":"Fineman","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2004.04.010_BIB13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1172\/JCI112884","article-title":"Glycemic threshold for activation of glucose conterregulatory systems are higher that the threshold for symptoms","volume":"79","author":"Schwartz","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2004.04.010_BIB14","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJM199512283332602","article-title":"Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus","volume":"333","author":"Boyle","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2004.04.010_BIB15","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2337\/diab.37.7.901","article-title":"Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release","volume":"37","author":"Amiel","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2004.04.010_BIB16","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2337\/diabetes.48.7.1429","article-title":"Hypoglycemia per se stimulates sympathetic neural as well as adrenomedullary activity, but, unlike the adrenomedullary response, the forearm sympathetic neural response is not reduced after recent hypoglycemia","volume":"48","author":"Paramore","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2004.04.010_BIB17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(94)91336-6","article-title":"Restoration of hypoglycemia awareness in patients with long duration insulin dependent diabetes mellitus","volume":"344","author":"Cranston","year":"1994","journal-title":"Lancet"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049504002069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049504002069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T02:06:21Z","timestamp":1758420381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049504002069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0026049504002069"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2004.04.010","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of pramlintide on symptom, catecholamine, and glucagon responses to hypoglycemia in healthy subjects","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2004.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}